NPHP1-Associated Senior-Løken Syndrome Shows Wide Retinal Diversity in Japanese Patients
A Japanese multicenter case series has mapped an unusually broad spectrum of retinal disease in NPHP1-associated Senior-Løken syndrome, ranging from cone or cone-rod dystrophy to retinitis pigmentosa, sector retinitis pigmentosa, pigmented paravenous retinochoroidal atrophy, and even a normal-appearing retina in one patient. The cohort also revealed a striking clinical sequence: in most cases, retinal disease came first, while kidney involvement followed later. For ophthalmologists and nephrologists who encounter children with unexplained early retinal degeneration, that order of events has direct diagnostic weight.
Twelve patients with biallelic pathogenic NPHP1 variants were studied across six ophthalmic centers in Japan. Ten came to attention as symptomatic probands, while two were affected siblings identified through family screening. The design was retrospective, but the clinical workup was broad and methodical: fundus photography, fundus autofluorescence (FAF), optical coherence tomography, electroretinography, and genetic testing with whole-exome or whole-genome sequencing. Follow-up stretched from 0 to 44 years, with a mean of 14.6 years, allowing the team to track how an inherited ciliopathy can unfold across childhood and beyond.
The phenotype was not uniform, and it did not behave like a single textbook entity. Four patients had cone or cone-rod dystrophy. Four had retinitis pigmentosa. Two showed sector retinitis pigmentosa. One patient had pigmented paravenous retinochoroidal atrophy, a pattern that can easily be mistaken for another retinal dystrophy if the systemic context is missed. One patient had a normal retina on examination, which is a reminder that genetic disease can exist before fundus changes become obvious.
FAF Patterns Point to a Shared Degenerative Signature
A particularly interesting imaging feature emerged on FAF. Five patients showed a descending tract, a pattern that may prove useful as a recognizable marker of retinal degeneration in this syndrome. In practical terms, FAF can capture abnormalities that are easy to underestimate on routine ophthalmoscopy, especially when early disease is subtle or when the retinal picture does not resemble a classic syndromic dystrophy.
The imaging finding matters because Senior-Løken syndrome sits at the intersection of retinal and renal ciliopathy. NPHP1 encodes a nephrocystin protein involved in ciliary function, and disruption of ciliary signaling can affect both photoreceptors and renal tubular cells. That shared biology helps explain why retinal dystrophy and nephropathy cluster in the same patient, but the timing of organ involvement can differ widely. In this series, the eye often declared the disorder before the kidney did.
Nine patients developed retinopathy before nephropathy. Every one of those nine was initially diagnosed with either Leber congenital amaurosis or early-onset retinal dystrophy, which shows how easily the early ocular presentation can be framed as an isolated eye disease until systemic surveillance reveals the broader syndrome. In a child with profound visual impairment or early retinal dysfunction, genetic testing for ciliopathy genes may be the step that prevents a delayed renal diagnosis.
The phenotype variability extended across families as well as within them. Some relatives carried the same underlying gene defect yet displayed different retinal appearances. Such inter- and intrafamilial variability is exactly what complicates bedside counseling: a family history of severe retinal disease does not guarantee the same retinal pattern in the next affected sibling, and renal timing may not mirror the eye findings in a predictable way.
Genetic Findings Reinforce NPHP1 as the Main Driver
Genetic analysis gave the cohort a strong molecular anchor. Eleven of the 12 patients carried a homozygous whole-NPHP1 deletion. One patient had compound heterozygous NPHP1 and EYS variants, a combination that raises the possibility of blended or modifying genetic effects on the retinal phenotype. The study does not claim a mechanistic hierarchy for the EYS finding, but the result adds an important caution: retinal appearance in a ciliopathy cohort may be influenced by more than one inherited variant.
The link between genotype and phenotype was not linear enough to support a narrow clinical template. A homozygous NPHP1 deletion did not produce a single retinal signature. Instead, the same molecular lesion was associated with multiple dystrophic patterns, including the less familiar paravenous atrophy pattern. For clinicians, that means the diagnostic threshold should not depend on whether the fundus matches a preferred syndrome label.
The renal implications are just as important. Senior-Løken syndrome is defined by the combination of retinal degeneration and nephronophthisis-related kidney disease, yet the eye can lead by years. When a child or young adult presents with early retinal dystrophy, especially if electroretinography and FAF suggest a syndromic process, renal evaluation should not wait for obvious urinary or systemic symptoms. The kidney disease may already be developing silently.
One sentence captures the bedside risk plainly: retinal disease frequently came first.
What This Means for Early Diagnosis and Surveillance
The clinical message from this Japanese series is not simply that NPHP1 disease is variable. It is that the variability itself can delay recognition. A child with cone-rod dystrophy may be worked up entirely within ophthalmology for some time, while a patient with sector retinitis pigmentosa or paravenous atrophy may not immediately trigger a ciliopathy workup. Yet the underlying diagnosis can carry major implications for renal surveillance, family screening, and long-term counseling.
FAF may deserve special attention in that process. The descending tract pattern observed in five patients could become a useful imaging clue when clinicians are trying to separate nonspecific early retinal dysfunction from a syndromic ciliopathy. OCT and electroretinography add structural and functional confirmation, but FAF may be the first modality to suggest that the retinal disease belongs to a broader inherited syndrome.
The study also broadens the retinal differential for NPHP1-associated Senior-Løken syndrome. Pigmented paravenous retinochoroidal atrophy is not a phenotype that most clinicians would place high on the list for this disorder, yet it appeared in this cohort. A normal retinal appearance in one patient further supports the need for longitudinal follow-up, because genetic disease can declare itself over time rather than all at once.
For families, the findings support cascade screening when an affected proband is identified. Two affected siblings were found only through family screening, a practical illustration of how molecular diagnosis can uncover disease that would otherwise remain unrecognized. The kidney and eye findings may not arrive together, but the genetic signal already exists in the family line.
This series stops short of answering how quickly nephropathy progresses once retinal disease appears, or whether any retinal pattern predicts a particular renal course. What it does show is more immediate and clinically useful: in NPHP1-associated Senior-Løken syndrome, the retinal presentation is broad, FAF may show a recurring descending tract, and ocular disease often precedes kidney involvement by a meaningful interval.